Patent details
EP2102191 Title: CRYSTALLINE FORMS OF SOLVATED ILAPRAZOLE
Basic Information
- Publication number:
- EP2102191
- PCT Application Number:
- PCT/US/2007/089137
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP078661071
- PCT Publication Number:
- WO/2008/083341
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- CRYSTALLINE FORMS OF SOLVATED ILAPRAZOLE
- French Title of Invention:
- FORMES CRISTALLINES D'ILAPRAZOLE SOLVATÉ
- German Title of Invention:
- KRISTALLINE FORMEN VON SOLVATISIERTEM ILAPRAZOL
- SPC Number:
Dates
- Filing date:
- 28/12/2007
- Grant date:
- 21/11/2012
- EP Publication Date:
- 21/11/2012
- PCT Publication Date:
- 10/07/2008
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 23/09/2009
- EP B1 Publication Date:
- 21/11/2012
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 28/12/2012
- Expiration date:
- 28/12/2027
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 28/12/2007
- Name:
- IL YANG PHARMACEUTICAL COMPANY LTD.
- Address:
- 182-4 Hagal-dong Giheung-gu, Yongin-si, Gyeonggi-do 449-726, Korea (Republic) (KR)
Inventor
1
- Name:
- BRACKETT John, M.
- Address:
- United States (US)
2
- Name:
- JONAITIS David, T.
- Address:
- United States (US)
3
- Name:
- PARENT Stephan, D.
- Address:
- United States (US)
4
- Name:
- LAI Wei
- Address:
- United States (US)
Priority
1
- Priority Number:
- 877608 P
- Priority Date:
- 29/12/2006
- Priority Country:
- United States (US)
2
- Priority Number:
- 887499 P
- Priority Date:
- 31/01/2007
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- C07D 401/14;
| Filing date | Document type | Number of pages |
|---|